ホーム › 膵臓がん › ミネソタ州 › Rochester
Rochester、MNにおける膵臓がんの臨床試験
Rochesterとその周辺地域（約30マイル以内）の拠点で、膵臓がんに関する22件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma
被験者募集中第2相
- Mayo Clinic in Rochester, Rochester
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
被験者募集中第1相
- Mayo Clinic Rochester, Rochester
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
被験者募集中観察研究
- Mayo Clinic Rochester, Rochester
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
被験者募集中第2/3相
- Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
- Mayo Clinic, Rochester
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
被験者募集中第3相
- Mayo Clinic Cancer Center, Rochester
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
被験者募集中第1/2相
- Mayo Clinic, Rochester
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
被験者募集中観察研究
- Mayo Clinic in Rochester, Rochester
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
被験者募集中第2相
- Mayo Clinic Rochester, Rochester
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
被験者募集中第2相
- Local Institution - 0129, Rochester
- Local Institution - 0174, Rochester
- Local Institution - 0181, Rochester
Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis
被験者募集中第2相
- Mayo Clinic in Rochester, Rochester
CREO - Microwave Ablation Feasibility Study
被験者募集中
- Mayo Clinic Rochester, Rochester
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
被験者募集中観察研究
- Mayo Clinic in Rochester, Rochester
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
被験者募集中第2相
- Mayo Clinical Rochester, Rochester
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
被験者募集中第1相
- Mayo Clinic, Rochester
Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma
被験者募集中第2相
- Mayo Clinic in Rochester, Rochester
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
被験者募集中第1/2相
- Mayo Clinic Rochester, Rochester
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
被験者募集中観察研究健康なボランティア歓迎
- Mayo Clinic in Rochester, Rochester
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
被験者募集中観察研究
- Mayo Clinic in Rochester, Rochester
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
被験者募集中第2相
- Ohio State University Telemedicine, Rochester
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
被験者募集中観察研究健康なボランティア歓迎
- Mayo Clinic, Rochester
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
被験者募集中第1/2相
- Mayo Clinic, Rochester
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
被験者募集中第1相
- Exelixis Clinical Site #14, Rochester
他の都市における膵臓がんの試験
- Houston, TX61件の研究
- New York City, NY60件の研究
- Boston, MA43件の研究
- Nashville, TN39件の研究
- Los Angeles, CA35件の研究
- St. Louis, MO33件の研究
- Arlington, VA33件の研究
- Baltimore, MD31件の研究
- San Antonio, TX31件の研究
- Philadelphia, PA26件の研究
- Tampa, FL26件の研究
- Durham, NC24件の研究
Rochesterにおける他の研究
- 乳がん42件の研究
- 非小細胞肺癌37件の研究
- 転移性癌31件の研究
- がん（全種類）30件の研究
- 卵巣がん29件の研究
- 大腸癌29件の研究
- 多発性骨髄腫24件の研究
- 心不全22件の研究
- 前立腺がん22件の研究
- 子宮内膜がん20件の研究
- 肺がん20件の研究
- 慢性リンパ性白血病18件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。